Prabu Nambiar, PhD, MBA, RAC

President and CEO

Prabu Nambiar is the Founder, President and CEO of PraNa Biosciences Inc. After his Ph.D. in Organic Chemistry from Oregon State University and post-doctoral training at Brown University, he started his pharmaceutical career at Bristol-Myers Squibb (BMS) in 1991. Prabu has also completed the Executive MBA program at Boston University. During his tenure in the industry, Prabu held positions of increasing responsibilities at BMS, Sepracor, Wyeth and Cubist Pharmaceuticals and finally as Vice President and Head of CMC Regulatory Affairs at Vertex Pharmaceuticals. In 2007, he started Syner-G Pharma Consulting, a 35 people strong CMC consulting firm providing CMC services for pharma/biotech firms of all stages. His flair for scientific problem solving in combination with a thirst for entrepreneurship compelled him to start PraNa Biosciences in 2015, with a goal of developing improved and new drugs. He and his team of like-minded people have already identified several target products in a short time and made significant progress in demonstrating the proof of concept. Prabu is a member of AAPS, ACS and RAPS. He was the 2009 Chair of the AAPS Regulatory Science section. He is a member of the USP Physical Analysis Expert Committee and Chair of the USP [1086 ] Expert panel.

Gary Maier, PhD

VP Clinical Development

Gary acquired his PhD in pharmaceutical sciences from the University of Buffalo and has over 30 years of pharmaceutical experience. He is an accomplished senior pharmaceutical industry executive with diverse experience especially in clinical pharmacology and allied fields of drug development. While at Sepracor he built a state the art clinical pharmacology department, comprised of bioanalytical sciences, ADME and clinical pharmacokinetics/modeling and simulation. He has been involved in and responsible for the successful submission of numerous NDA’s, sNDA’s and regulatory briefing documents, across a broad array of therapeutics areas. Over the course of his career he has held increasing levels of responsibility and was a VP of clinical pharmacology. Gary is a member of AAPS and ASCPT and also is an adjunct professor at the University of New England, School of Pharmacy.

Geevarghese Easo, BS

VP, R&D Operations

Geevarghese Easo (“Gee”) is the VP R&D Operations at PraNa Biosciences. Gee received his Diploma and BS degrees in Pharmaceutical Sciences in India from St. John’s College and Vivekananda College, respectively. Gee started his pharma industry career at Kali Laboratories in 2001 as a R&D Chemist focused on Analytical Sciences and contributed to the successful FDA filing and approval of several ANDAs. After the acquisition of Kali Labs by Par Pharmaceuticals in 2004, he continued his role with increasing responsibilities that also included Quality and Compliance. In 2009, Gee was affiliated with Sun Pharmaceuticals before moving to Ranbaxy Laboratories where he spent 6 years in the QA function responsible for regulatory compliance, product quality and data integrity. Gee has a passion for pharmaceutical problem solving using in the fast-paced entrepreneurial setting. In 2015, he decided to realize this dream by accepting the role of Head of R&D Operations at PraNa Biosciences. Under his leadership, PraNa has built a fit for purpose R&D lab carrying out product development activities that has resulted in several promising leads with improved in-vitro and in-vivo performance. Gee will continue to lead the R&D operations in support of product development for clinical studies, ultimately leading to commercial production via internal and outsourced channels.

William E. O’Brien, Esq.

VP Senior Business and Legal Advisor

Senior business and legal advisor and executive with extensive corporate and technology intellectual property and transactional experience. Extensive experience in establishing, counseling and representing US and international companies and individuals. Strong commercial focus and solution orientation, from negotiations through execution and operational phases. Extensive law firm, in-house and government experience with intellectual property and commercial issues. Corporate development expertise focusing on the critical transition period from entrepreneurial start-up/early stage companies to professionally managed organizations with the operational and compliance processes necessary to nurture and grow businesses. Industry experience primarily in the fields of pharmaceutical and medical devices, software, hardware, fashion and consumer products. Operational roles in coordinating strategic relationships with investors, suppliers and customers, as well as international expansion. Specialties: Trademark and copyright prosecution and enforcement, contracts, licensing, corporate governance and other commercial and operational matters.

Binesh Prabhakar, M.S., MBA

VP, Corporate Development and Strategy

Binesh is a founding member and currently serves as our head of corporate development and strategy at Prana. Binesh held executive leadership roles at various pharmaceutical consulting firms with responsibility for client relationships, business development, business operations and finance, and strategic planning. Prior to Prana, Binesh started Cambridge IT Compliance, LLC, a GxP IT/Quality Assurance consulting firm that provides full spectrum of cGMP consulting services. Cambridge IT serves several Boston/North East pharmaceutical and biotech clients. Binesh holds an MBA from Babson College, M.S. from Texas A&M University-Corpus Christi, and B.E. from St. Joseph’s College affiliated to the University of Madras, Chennai, India. Specialties: Business Development, Strategy and Operations.